University of Nantes
France
Philippe Moullier mainly investigates Genetic enhancement, Immunology, Virology, Vector and Adeno-associated virus. The study incorporates disciplines such as Transgene, Viral vector and Transduction in addition to Genetic enhancement. His research integrates issues of Adenoviridae, Systemic administration, Pharmacology and Pathology in his study of Immunology.
The concepts of his Virology study are interwoven with issues in Genetic transfer and Recombinant DNA. His Recombinant DNA study combines topics in areas such as Titer, Molecular biology and Cell biology. His Vector research includes elements of Virus, Immunosuppression and Regulation of gene expression.
The scientist’s investigation covers issues in Genetic enhancement, Molecular biology, Virology, Recombinant DNA and Transgene. The various areas that Philippe Moullier examines in his Genetic enhancement study include Vector, Duchenne muscular dystrophy, Immunology and Pathology. His Molecular biology study integrates concerns from other disciplines, such as Cell culture, Viral replication, Complementary DNA, Viral vector and Polymerase chain reaction.
His work carried out in the field of Virology brings together such families of science as Gene, Transfection, Transduction and Adeno-associated virus. In his study, Secretion is strongly linked to In vivo, which falls under the umbrella field of Recombinant DNA. His work deals with themes such as Regulation of gene expression, Gene expression, Transactivation and Retina, which intersect with Transgene.
Genetic enhancement, Vector, Duchenne muscular dystrophy, Virus and Molecular biology are his primary areas of study. His work carried out in the field of Genetic enhancement brings together such families of science as Transgene, Bioinformatics, Virology, Viral vector and DNA sequencing. His Transgene study incorporates themes from Phenotype and Immune system.
His study on Vector is covered under Recombinant DNA. His Virus study integrates concerns from other disciplines, such as Adeno-associated virus and Transduction. His Molecular biology research incorporates elements of Natural killer T cell, T cell, Interleukin 21 and CD8.
Philippe Moullier focuses on Genetic enhancement, Vector, Virology, Genome and Real-time polymerase chain reaction. The various areas that he examines in his Genetic enhancement study include Retinal degeneration, Neuromuscular disease, Pathology, Dystrophin and ITGA7. His research investigates the link between Vector and topics such as Titer that cross with problems in Plasmid and Computational biology.
His Virology research is multidisciplinary, incorporating elements of Adeno-associated virus, Viral vector and DNA, DNA sequencing. His work in Genome is not limited to one particular discipline; it also encompasses Recombinant DNA. Philippe Moullier has included themes like In vivo and Plasmapheresis in his Virus study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
Sandra Duque;Béatrice Joussemet;Christel Riviere;Thibaut Marais;Thibaut Marais.
Molecular Therapy (2009)
Factors influencing recombinant adeno-associated virus production.
Anna Salvetti;Soizic Orève;Gilliane Chadeuf;David Favre.
Human Gene Therapy (1998)
Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts.
Philippe Moullier;Delphine Bohl;Jean-Michel Heard;Olivier Danos.
Nature Genetics (1993)
Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery.
Michel Weber;Joseph Rabinowitz;Nathalie Provost;Hervé Conrath.
Molecular Therapy (2003)
Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells
D Nègre;P E Mangeot;G Duisit;S Blanchard.
Gene Therapy (2000)
Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium
G Le Meur;K Stieger;A J Smith;M Weber.
Gene Therapy (2007)
Control of erythropoietin delivery by doxycycline in mice after intramuscular injection of adeno-associated vector
Delphine Bohl;Anna Salvetti;Philippe Moullier;Jean Michel Heard.
Blood (1998)
Composition for the in vivo production of therapeutic products
Beuzard Yves;Danos Olivier;Descamps Vincent;Heard Jean-Michel.
(1994)
Adeno-Associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle
Magalie Penaud-Budloo;Caroline Le Guiner;Ali Nowrouzi;Alice Toromanoff.
Journal of Virology (2008)
Lack of an Immune Response against the Tetracycline-Dependent Transactivator Correlates with Long-Term Doxycycline-Regulated Transgene Expression in Nonhuman Primates after Intramuscular Injection of Recombinant Adeno-Associated Virus
David Favre;Véronique Blouin;Nathalie Provost;Radec Spisek.
Journal of Virology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
REGENXBIO Inc.
Inserm
University College London
Institut Pasteur
University of Modena and Reggio Emilia
Royal Holloway University of London
University of Nantes
Harvard Medical School
Institut Gustave Roussy
Claude Bernard University Lyon 1
University of Tennessee at Knoxville
Aalborg University
RMIT University
University of Hong Kong
University of Glasgow
Chinese Academy of Sciences
University of Delhi
University of Groningen
Leibniz Association
University of Tübingen
MRC Laboratory of Molecular Biology
University of East Anglia
University of Bristol
Columbia University
University of Michigan–Ann Arbor
Boston University